Hosted on MSN2d
Goldman Sachs Has 4 Strong Buy Dividend Energy Stocks With Up to 50% Upside Potential
Goldman Sachs is the world's second-largest investment bank by revenue, and it ranks 55th on the Fortune 500 list of the ...
Investors seeking alpha should focus on 3 industries: Goldman Sachs
Investors seeking to outperform the market should focus their stock-picking efforts on volatile names in the consumer ...
The Goldman Sachs Group Cuts CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $57.00
CRISPR Therapeutics (NASDAQ:CRSP – Free Report) had its price objective cut by The Goldman Sachs Group from $66.00 to $57.00 ...
Deepseek's promise in China comes with a workforce warning: Goldman Sachs
Goldman Sachs anticipates that by 2030, it estimated that AI-driven advancements could contribute an additional 0.2 to 0.3 ...
Goldman Sachs Reaffirms Their Hold Rating on GlaxoSmithKline (GSK)
Goldman Sachs analyst Rajan Sharma maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £16.80.
The Goldman Sachs Group Downgrades Informatica (NYSE:INFA) to Neutral
The Goldman Sachs Group downgraded shares of Informatica (NYSE:INFA – Free Report) from a buy rating to a neutral rating in a research note released on Friday morning, Marketbeat Ratings reports. A ...
Goldman Sachs abandons DEI rule, saying it has ‘served its purpose’
Goldman Sachs has ended a ban on underwriting companies with all-White, all-male boards, becoming the latest corporate giant ...
Goldman Sachs explains axing DEI rule which has ‘served its purpose’
Goldman Sachs have become the latest company to scrap their diversity programmes following the Trump administration’s signing ...